SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-del-Castillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Eng J Med 1988; 319: 81723.
  • 2
    Nihoyannopoulos P, Gomez PM, Joshi J, Loizou S, Walport MJ, Oakley CM. Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies. Circulation 1990; 82: 36975.
  • 3
    Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990; 335: 15414.
  • 4
    Cervera R, Font J, Pare C, Azqueta M, Perez-Villa F, Lopez-Soto A, et al. Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 1992; 51: 1569.
  • 5
    Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20: 112734.
  • 6
    Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematosus. Am Heart J 1993; 125: 11239.
  • 7
    Jouhikainen T, Pohjola-Sintonen S, Stephansson E. Lupus anticoagulant and cardiac manifestations in systemic lupus erythematosus. Lupus 1994; 3: 16772.
  • 8
    Vianna JL, Khamashta MA, Ordi-Ros J, Font J, Cervera R, López-Soto A, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 1994; 96: 39.
  • 9
    Gabrielli F, Alcini E, di Prima MA, Mazzacurati G, Masala C. Cadiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol 1995; 51: 11726.
  • 10
    Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335: 142430.
  • 11
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 12
    Brandt JT, Triplett DA, Alving B, Scharrer I, and the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 118590.
  • 13
    Eisenberg MJ, Oken K, Guerrero S, Saniei MA, Schiller NB. Prognostic value of echocardiography in hospitalized patients with pericardial effusion. Am J Cardiol 1992; 70: 9349.
  • 14
    Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987; 75: 17583.
  • 15
    Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, et al, and the American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003; 16: 777802.
  • 16
    Myerowitz PD, Michaelis LL, McIntosh CL. Mitral valve replacement for mitral regurgitation due to Libman-Sacks endocarditis: report of a case. J Thorac Cardiovasc Surg 1974; 67: 86974.
  • 17
    Murray FT, Fuleihan DS, Cornwall CS, Pinals RS. Acute mitral regurgitation from ruptured chordae tendineae in systemic lupus erythematosus. J Rheumatol 1975; 2: 4549.
  • 18
    Yates DB, Scott JT. Cardiac valvular disease in chronic inflammatory disorders of connective tissue: factors influencing survival after surgery. Ann Rheum Dis 1975; 34: 3215.
  • 19
    Bulkey BH, Roberts WC. Systemic lupus erythematosus as a cause of severe mitral regurgitation: new problem in an old disease. Am J Cardiol 1975; 35: 3058.
  • 20
    Paget SA, Bulkley BH, Grauer LE, Seningen R. Mitral valve disease of systemic lupus erythematosus: a cause of severe congestive heart failure reversed by valve replacement. Am J Med 1975; 59: 1349.
  • 21
    Mossard JM, Walter P, Brechenmacher C, Voegtlin R. Cardiac involvement in a lupus syndrome: clinical and morphological study apropos of one case necessiting a double valve replacement. Arch Mal Coeur Vaiss 1977; 70: 12038. In French.
  • 22
    Vaughton KC, Walker DR, Sturridge MF. Mitral valve replacement for mitral stenosis caused by Libman-Sacks endocarditis. Br Heart J 1979; 41: 7303.
  • 23
    Kinney EL, Wynn J, Ward S, Babb JD, Wine-Shaffer C, Zelis R. Ruptured chordae tendineae: its association with systemic lupus erythematosus. Arch Pathol Lab Med 1980; 104: 5956.
  • 24
    Milne JR, Doyle DV, Banim SE, Huskisson EC. Systemic lupus erythematosus as a cause of severe mixed mitral valve disease. J Rheumatol 1981; 8: 5168.
  • 25
    Rawsthorne L, Ptacin MJ, Choi H, Olinger GN, Bamrah VS. Lupus valvulitis necessitating double valve replacement. Arthritis Rheum 1981; 24: 5614.
  • 26
    Evans DT, Sloman JG. Mitral stenosis and mitral incompetence due to Libman-Sacks endocarditis with mitral valve replacement. Aust N Z J Med 1981; 11: 5268.
  • 27
    Dajee H, Hurley EJ, Szarnicki RJ. Cardiac valve replacement in systemic lupus erythematosus: a review. J Thorac Cardiovasc Surg 1983; 85: 71826.
  • 28
    Brennan FJ, Ford SE, Ford PM, Morrin PA, Burggraf GW, Salerno TA. Mitral regurgitation due to lupus endocarditis treated with valve replacement. Can Med Assoc J 1983; 129: 5847.
  • 29
    Sanchez G, Lintermans J, Sambon F, Jaumin P, Gosseye S, Tremouroux M, et al. Mitral valve replacement in an infant with disseminated lupus erythematosus and Libman-Sacks endocarditis. Arch Mal Coeur Vaiss 1983; 76: 6226. In French.
  • 30
    Moynihan T, Hansen R, Troup P, Olinger G. Simultaneous aortic and mitral valve replacement for lupus endocarditis: report of a case and review of the literature. J Thorac Cardiovasc Surg 1988; 95: 1425.
  • 31
    Ford PM, Ford SE, Lillicrap DP. Association of lupus anticoagulant with severe valvular heart disease in systemic lupus erythematosus. J Rheumatol 1988; 15: 597600.
  • 32
    Straaton KV, Chatham WW, Reveille JD, Koopman WJ, Smith SH. Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med 1988; 85: 64550.
  • 33
    Ferraris VA, Hawksley VC, Rabinowitz M, Coyne CM, Sullivan TJ, Sprague MS. Double valve replacement for lupus valvulitis: report of a case and review of the literature. Tex Heart Inst J 1990; 17: 5660.
  • 34
    Hachulla E, Bataille D, Janin A, Gilliot JM, Gosset D, Warembourg H, et al. Double heart valve replacement disclosing antiphospholipid syndrome. Rev Med Interne 1992; 13: 2214. In French.
  • 35
    Alameddine AK, Schoen FJ, Yanagi H, Couper GS, Collins JJ Jr, Cohn LH. Aortic or mitral valve replacement in systemic lupus erythematosus. Am J Cardiol 1992; 70: 9556.
  • 36
    Durand I, Blaysat G, Chauvaud S, Tron P, Tron F, Mallet E, et al. Extensive fibrous endocarditis as first manifestation of systemic lupus erythematosus. Arch Fr Pediatr 1993; 50: 6858. In French.
  • 37
    Kalangos A, Panos A, Sezerman O. Mitral valve repair in lupus valvulitis: report of a case and review of the literature. J Heart Valve Dis 1995; 4: 2027.
  • 38
    Chauvaud SM, Kalangos A, Berrebi AJ, Gaer AR, Acar C, Carpentier AF. Systemic lupus erythematosus valvulitis: mitral valve replacement with a homograft. Ann Thorac Surg 1995; 60: 18035.
  • 39
    Gordon RJ, Weilbaecher D, Davy SM, Safi HJ, Quinones MA, DeFelice CA, et al. Valvulitis involving a bioprosthetic valve in a patient with systemic lupus erythematosus. J Am Soc Echocardiogr 1996; 9: 1047.
  • 40
    Morin AM, Boyer AS, Nataf P, Gandjbakhch I. Mitral insufficiency caused by systemic lupus erythematosus requiring valve replacement: three case reports and a review of the literature. Thorac Cardiovasc Surg 1996; 44: 3136.
  • 41
    Hakim JP, Mehta A, Jain AC, Murray GF. Mitral valve replacement and repair: report of 5 patients with systemic lupus erythematosus. Tex Heart Inst J 2001; 28: 4752.
  • 42
    Yoshida M, Sasako Y, Kobayashi J, Minatoya K, Bando K, Kitamura S. Mitral valve plasty in systemic lupus erythematosus in the setting of antiphospholipid syndrome. Jpn J Thorac Cardiovasc Surg 2000; 48: 3913.
  • 43
    Kato Y, Isobe F, Sasaki Y, Kumano H, Nagamachi K, Arimoto H. Secondary mitral valve replacement in antiphospholipid syndrome and chronic renal failure. Jpn J Thorac Cardiovasc Surg 2001; 49: 72831.
  • 44
    Moyssakis I, Tzioufas A, Triposkiadis F, Strateges N, Kyriakidis M. Severe aortic stenosis and mitral regurgitation in a woman with systemic lupus erythematosus. Clin Cardiol 2002; 25: 1946.
  • 45
    Chauvaud S, Waldmann T, d'Attellis N, Bruneval P, Acar C, Gerota J, et al. Homograft replacement of the mitral valve in young recipients: mid-term results. Eur J Cardiothorac Surg 2003; 23: 5606.
  • 46
    Georghiou GP, Shapira Y, Drozd T, Erez E, Raanani E, Vidne BA, et al. Double-valve Libman-Sacks endocarditis: an entity that demands special consideration. J Heart Valve Dis 2003; 12: 797801.
  • 47
    Erkan D, Leibowitz E, Berman J, Lockshin MD. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. J Rheumatol 2002; 29: 8439.
  • 48
    Ciocca RG, Choi J, Graham AM. Antiphospholipid antibodies lead to increased risk in cardiovascular surgery. Am J Surg 1995; 170: 198200.
  • 49
    Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, Fedderly BJ, Freed MD, et al. Guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998; 98: 194984.
  • 50
    Lockshin M, Tenedios F, Petri M, McCarty G, Forastiero R, Krilis S, et al. Cardiac disease in the antiphospholipid syndrome: recommendations for treatment: committeee consensus report. Lupus 2003; 12: 51823.